Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Where are new schizophrenia drugs? Experts convene to explore genetic and epigenetic solutions

By R&D Editors | March 4, 2011

Where are new schizophrenia drugs? Experts convene to explore genetic and epigenetic solutions

NEW YORK, March 4, 2011 – Despite significant investment in research and development by pharmaceutical companies, the last decade has seen a marked decline in the number of drugs developed and approved for schizophrenia. A multi-day symposium at the New York Academy of Sciences on Wednesday, March 9 ? Friday, March 11 will convene world-leading experts in clinical, translational, and basic neuroscience to address this problem by examining novel, state-of-the-art approaches to schizophrenia drug development.

More than 20 speakers will describe a variety of promising approaches to developing therapies, including using genetic studies to identify new targets, improving animal models, targeting the epigenome, identifying new small molecule targets, and understanding the functioning of neural circuits. To register or for more information, see www.nyas.org/Schizophrenia2011.

WHAT:

A Scientific Symposium: Advancing Drug Discovery for Schizophrenia

WHO:

Organizers

Stephen Marder, MD, University of California, Los Angeles School of Medicine

Bita Moghaddam, PhD, University of Pittsburgh

Bryan Roth, MD, PhD, University of North Carolina School of Medicine

Keynote Speakers:

Eric J.Nestler, MD, PhD, Mount Sinai Medical Center

Edward Scolnick, MD, The Broad Institute of Massachusetts Institute of Technology and Harvard University

Patrick F.Sullivan, MD, The University of North Carolina at Chapel Hill

WHEN:

Wednesday, March 9, 2011 | 5:30 pm ? poster session/reception
Thursday, March 10, 2011 | 8:00 am ? 6:00 pm
Friday, March 11, 2011 | 8:15 am ? 6:00 pm

WHERE:

The New York Academy of Sciences
7 World Trade Center, 250 Greenwich St., 40th floor, New York, NY

SOURCE

Related Articles Read More >

Why IBM predicts quantum advantage within two years
Aardvark AI forecasts rival supercomputer simulations while using over 99.9% less compute
This week in AI research: Latest Insilico Medicine drug enters the clinic, a $0.55/M token model R1 rivals OpenAI’s $60 flagship, and more
How the startup ALAFIA Supercomputers is deploying on-prem AI for medical research and clinical care
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE